The Food and Drug Administration on Aug. 23 granted full approval for the first vaccine for the prevention of COVID-19.
The vaccine, previously referred to as the Pfizer-BioNTech COVID-19 Vaccine, will be marketed as Comirnaty, “for the prevention of COVID-19 disease in individuals 16 years of age and older,” according to an FDA news release. The FDA also said the vaccine will continue to be available under emergency use authorization for individuals aged 12-15 and for the administration of a third dose in certain immunocompromised individuals.
View more COVID-19 news as it pertains to the dental profession.
